fda warning letters compounded semaglutide tirzepatide september 2025 issued a letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially FDA Takes Aim at Hims

Diabetologia 67 , 14801492 (2024)

However, this drug is usually indicated for the treatment of weight loss in people who have at least one of the following conditions: type 2 diabetes, high blood pressure, dyslipidemia, or cardiovascular disease

The study found that those who started on GLP-1-RAs had a lower risk of all-cause mortality and major cardiovascular events, such as heart attacks and strokes, compared to those who started on DPP-4is

Plan your 6 to 8 week thyroid check to fall during or shortly after this phase

Binding affinity occurs at nanomolar levels

Additionally, GLP-1 can prevent the insulin from expelling glucagon, which otherwise raises blood sugar